icotec ag Receives Approvals for Two KONG® VBR Spinal Systems Made with BlackArmor® and Ti-iT® in Europe and the US

June 18, 2020

icotec ag announces that the KONG®-TL and the KONG®-C vertebral body replacement systems with the unique Titanium coating (Ti-iT®) receive FDA 510(k) clearance in the United States and CE approval in Europe.

icotec ag CEO Roger Stadler said, “This is exciting news for icotec ag and our team as it allows us to expand our portfolio in multiple countries simultaneously, to include implants made from radiolucent, nonmetallic BlackArmor® material with a 360° osseoconductive Ti-iT® pure titanium coating.”

The surgical replacement of vertebral bodies is a common procedure after the removal of tumors from the spinal column or after a serious spinal fracture. A vertebral body replacement implant (VBR) is used to reconstruct and stabilize the spinal column. The surgical requirements for these stabilization procedures are met by the broad, innovative and technology platform developed by icotec ag.

  • The fully modular design of these VBR systems with endplates in various profiles, sizes, angles and alignments complements the expandability afforded by the KONG®-TL VBR E (thoracolumbar) for the thoracic and lumbar spine providing surgeons with a great deal of flexibility in the surgical planning process. With the KONG®-C VBR for the cervical spine, the curved implant body ensures optimal adaptation to the anatomy of the patient.
  • The 360° Ti-iT® pure titanium coating from icotec ag allows for the rapid engraftment of bone onto the implant thanks to the optimized osseoconductive structure.
  • The unique icotec BlackArmor® Carbon/PEEK implant material enables artefact-free imaging to be carried out and, most notably, the improved planning, application, and follow-up care of radiotherapy for patients with tumors.

With over 15 years of clinical success and more than 40,000 implants made from the unique BlackArmor® material, icotec ag is the leading provider of Carbon/PEEK implants. As the global market leader in the surgical treatment of vertebral tumors, icotec ag has set a target of establishing a complete product portfolio that provides patients with improved therapy options. “With the imminent market launch of the KONG®-TL/C vertebral body replacement systems in Europe and the US, we have made significant strides toward achieving this target,” commented Roger. He continues, “These systems perfectly complement the icotec ag pedicle screw systems already in surgical use.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy